Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Application of 5-oxo-4-alkenylene-pyrazole derivative in preparing anti-tumor medicament

A technology of pyrazole derivatives and alkenylene, which is applied in the field of genetic engineering and chemistry to achieve obvious effects of tumor suppression, reduction of damage to normal cells, and good specificity

Inactive Publication Date: 2012-07-25
FUDAN UNIV
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0019] 2. Cell cycle specific drugs only have a strong effect on a certain phase of the proliferation cycle, such as drugs that inhibit nucleic acid synthesis have a significant effect on the S phase; vinblastine, etc. act on the M phase
The dose-response curve of this kind of drug to bone marrow and tumor cells also decreases with the increase of dose, but when it reaches a certain dose, it turns to the horizontal direction and becomes a plateau, that is, if the dose is increased again, no more cells will be killed

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of 5-oxo-4-alkenylene-pyrazole derivative in preparing anti-tumor medicament
  • Application of 5-oxo-4-alkenylene-pyrazole derivative in preparing anti-tumor medicament
  • Application of 5-oxo-4-alkenylene-pyrazole derivative in preparing anti-tumor medicament

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0041] Embodiment 1MTS method measures the growth inhibitory effect of FD10 on SK-Hep1 cells

[0042] Human liver cancer cell line SK-Hep1 cells (ATCC company) 2~5×10 3 Each well was inoculated into a 96-well plate, cultured for 24 hours to allow it to adhere to the wall, and then FD10 (Interchim, UZI / 9516006) was added to set up 6 concentration gradients and 3 replicate wells for each concentration. Cells at 37°C, 5% CO 2 After culturing for 72 hours under the same conditions, discard the culture medium, and use the MTS kit (Promega Company) to measure the cell survival rate. The test method is as follows: wash the cells once with serum-free medium, and add the pre-prepared MTS chromogenic solution (add 2 ml of solution 1 and 100 μl of solution 2 to 10 ml of serum-free medium, and mix thoroughly). A well without cells was set as the background well to correct for the background light absorption of the solution. Put the cells into the cell incubator and continue to culture ...

Embodiment 2

[0045] Effect of embodiment 2FD10 on cell cycle

[0046] Human liver cancer cell lines HepG2 cells (ATCC Company), 7721 cells (ATCC Company) and SK-CYPJ stable cell lines (constructed and preserved in our laboratory) 3×10 5 Inoculate in a 60mm cell culture dish per dish, and add FD10 after culturing for 24 hours to make it adhere to the wall. 37°C CO 2 The incubator was cultivated for 48hr. Collect the cell culture medium and cells together into a cytocentrifuge tube, centrifuge at 1000 rpm for 10 min, and discard the supernatant. The cells were washed once with 2ml of pre-cooled 1×PBS, centrifuged at 1000rpm for 10min, and the supernatant was discarded. Fix with 70% pre-cooled ethanol at 4°C for 2hr or longer (overnight is also acceptable). Centrifuge at 1000rpm for 10min, and carefully suck off the supernatant. Resuspended with 500-1000μl PI staining solution, stained in the dark at room temperature for 20min, filtered the membrane, and detected the cell cycle changes by...

Embodiment 3

[0056] Effect of embodiment 3FD10 on clone formation rate

[0057] 1000 cells / dish of SK-Hep1 cells (ATCC Company) were inoculated on 60 mm cell culture dishes, one group was added with FD10, and the other group was added with DMSO as a control. Continuously cultivate for 15-20 days, and change the medium as appropriate in the middle. Wash once with room temperature 1×PBS, add 2ml of pre-cooled methanol and fix at 4°C for 10min. Discard the methanol used for fixation, wash once with pre-cooled 1×PBS, add GIMESA stain, stain at room temperature for 10 min, wash 3 times with water, remove floating color, take pictures, and count.

[0058] The clone size is determined according to the number of cells. Those larger than 200 cells are called large clones, those between 100-200 cells are called medium clones, and those between 50-100 cells are called small clones. Comparing the difference between large and medium clones, repeating 2 times and taking the average of three dishes eac...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention belongs to the field of genetic engineering and chemistry and relates to the application of 5-oxo-4-alkenylene-pyrazole derivatives in the preparation of anti-tumor drugs. The biomedical field is focused on finding novel anti-tumor drugs with low side effects, therefore, the invention provides the application of 2-{2-bromo-6-methoxy-4-[(Z)-(5-oxo-1,3-diphenyl-1,5-dihydro-4H-pyrazol-4-ylidene)methyl]phenoxy}acetamide, a small-molecule compound, in preparing the anti-tumor drugs. The compound can obviously inhibit the proliferation of tumor cells and slow down the growth rate of mouse tumors, moreover, the compound, which is designed for the CYPJ protein structure of cellular targets, has particularly obvious effect on the tumor cells of highly-expressed CYPJ protein, therefore, by developing the small-molecule compound as a novel anti-tumor drug, the invention has obvious anti-tumor effect, reduces the damage on normal cells and ensures the good specificity.

Description

technical field [0001] The invention relates to the fields of genetic engineering, chemistry and medicine, and relates to the application of a 5-oxo-4-alkenylene-pyrazole derivative in the preparation of anti-liver cancer drugs. Background technique [0002] Tumor is a disease caused by excessive cell proliferation. Malignant tumor has become one of the most important causes of human death. For a long time, cancer has almost equated with death. Therefore, many cancer patients, when they know that they have cancer, are severely hit mentally, and some even have mental breakdowns, can't sleep, blood gas drops rapidly, and their condition deteriorates rapidly. [0003] Tumor treatments include surgery, chemotherapy, radiotherapy, and biological therapy. The market for antineoplastic drugs used in the course of cancer treatment has been growing. According to the statistics of Frost & Sullivan, an American medical consulting company, the total sales of the global anticancer drug...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K31/4152A61P35/00
Inventor 余龙张明君胡海荣孙庆文唐丽莎
Owner FUDAN UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products